Status:
COMPLETED
The Impact of the COVID-19 Pandemic on Diabetes Management
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Type 2 Diabetes
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
The "CoDiaM study" examines how diabetes management and outcomes are changing during the COVID-19 pandemic and whether these changes are influenced by socio-demographic factors, health literacy, self-...
Detailed Description
The Covid-19 pandemic created new challenges for patients with diabetes and their treating physicians. In order to protect people from SARS-COV-2 infections, social contacts were reduced by restrictio...
Eligibility Criteria
Inclusion
- being 18 years or older, and
- having diabetes type 2 or type 1, and
- having consulted the practice at least once in 2019 AND at least once in 2020
Exclusion
- no capacity to consent (e.g. because of dementia)
- insufficient German language skills to understand the questions in the questionnaire
- not able to fill out the questionnaire (e.g. because of blindness)
- gestational diabetes
Key Trial Info
Start Date :
April 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
1503 Patients enrolled
Trial Details
Trial ID
NCT04821921
Start Date
April 9 2021
End Date
September 15 2022
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246